Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

Gastroenterol Rep (Oxf) · 2026 · PMC13262740 · PMID 42294460

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Adjusted mean IBS-SSS scores were consistently lower in Alcat-based diet group compared with the control group [β coefficient -22.1 (-92.1 to 47.8), P = 0.529], although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.